BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kohmer N, Rühl C, Ciesek S, Rabenau HF. Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies. J Clin Med 2021;10:2128. [PMID: 34069088 DOI: 10.3390/jcm10102128] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 26.0] [Reference Citation Analysis]
Number Citing Articles
1 Perkmann T, Mucher P, Ösze D, Müller A, Perkmann-nagele N, Koller T, Radakovics A, Flieder I, Repl M, Marculescu R, Wolzt M, Wagner OF, Binder CJ, Haslacher H. Comparison of five Anti-SARS-CoV-2 antibody assays across three doses of BNT162b2 reveals insufficient standardization of SARS-CoV-2 serology. Journal of Clinical Virology 2022. [DOI: 10.1016/j.jcv.2022.105345] [Reference Citation Analysis]
2 El-ghitany EM, Hashish MH, Farghaly AG, Omran EA. Determining the SARS-CoV-2 Anti-Spike Cutoff Level Denoting Neutralizing Activity Using Two Commercial Kits. Vaccines 2022;10:1952. [DOI: 10.3390/vaccines10111952] [Reference Citation Analysis]
3 Lee B, Ko JH, Lee KH, Kim YC, Song YG, Park YS, Baek YJ, Ahn JY, Choi JY, Song KH, Kim ES, Bae S, Kim SH, Jeong HW, Kim SW, Kwon KT, Kim SH, Jeong H, Kim B, Kim SS, Choi WS, Peck KR, Kang ES. Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding Domain. Microbiol Spectr 2022;:e0266922. [PMID: 36250875 DOI: 10.1128/spectrum.02669-22] [Reference Citation Analysis]
4 Devi MJ, Gaffar S, Hartati YW. A review post-vaccination SARS-CoV-2 serological test: Method and antibody titer response. Anal Biochem 2022;:114902. [PMID: 36122603 DOI: 10.1016/j.ab.2022.114902] [Reference Citation Analysis]
5 Springer DN, Perkmann T, Jani CM, Mucher P, Prüger K, Marculescu R, Reuberger E, Camp JV, Graninger M, Borsodi C, Deutsch J, Lammel O, Aberle SW, Puchhammer-Stöckl E, Haslacher H, Höltl E, Aberle JH, Stiasny K, Weseslindtner L. Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant. Microbiol Spectr 2022;:e0212922. [PMID: 36005839 DOI: 10.1128/spectrum.02129-22] [Reference Citation Analysis]
6 Wang X, Han M, Fuentes LR, Thwin O, Grobe N, Wang K, Wang Y, Kotanko P. SARS-CoV-2 neutralizing antibody response after three doses of mRNA1273 vaccine and COVID-19 in hemodialysis patients. Front Nephrol 2022;2. [DOI: 10.3389/fneph.2022.926635] [Reference Citation Analysis]
7 Kim DK, Jung SW, Moon J, Jeong KH, Hwang HS, Kim JS, Lee S, Kang S, Kim YG. Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response After Heterologous Immunizations With ChAdOx1/BNT162b2 in End-Stage Renal Disease Patients on Hemodialysis. Front Immunol 2022;13:894700. [DOI: 10.3389/fimmu.2022.894700] [Reference Citation Analysis]
8 Kang C, Lee N, Lin C, Hsu Y, Chang Y, Chung M, Lee Y, Tseng W, Wu J, Chen S, Lu M, Ko W, Lee P, Hsueh P. Immunogenicity and safety of homologous and heterologous ChAdOx1-S and mRNA-1273 vaccinations in healthy adults in Taiwan. Journal of Clinical Virology 2022;150-151:105156. [DOI: 10.1016/j.jcv.2022.105156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Patyna S, Eckes T, Koch BF, Sudowe S, Oftring A, Kohmer N, Rabenau HF, Ciesek S, Avaniadi D, Steiner R, Hauser IA, Pfeilschifter JM, Betz C. Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response. Vaccines 2022;10:585. [DOI: 10.3390/vaccines10040585] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
10 Saker K, Pozzetto B, Escuret V, Pitiot V, Massardier-pilonchéry A, Mokdad B, Langlois-jacques C, Rabilloud M, Alfaiate D, Guibert N, Fassier J, Bal A, Trouillet-assant S, Trabaud M. Evaluation of Commercial Anti-SARS-CoV-2 Neutralizing Antibody Assays in seropositive subjects. Journal of Clinical Virology 2022. [DOI: 10.1016/j.jcv.2022.105169] [Reference Citation Analysis]
11 Cuadrado A, Del Barrio M, Fortea JI, Amigo L, San Segundo D, Rodriguez-Cundin MP, Rebollo MH, Fernandez-Santiago R, Castillo F, Achalandabaso M, Echeverri J, Anderson EJ, Rodríguez-Sanjuan JC, López-Hoyos M, Crespo J, Fábrega E. Antibody response to the messenger RNA-1273 vaccine (Moderna) in liver transplant recipients. Hepatol Commun 2022. [PMID: 35344281 DOI: 10.1002/hep4.1937] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Komissarov AA, Dolzhikova IV, Efimov GA, Logunov DY, Mityaeva O, Molodtsov IA, Naigovzina NB, Peshkova IO, Shcheblyakov DV, Volchkov P, Gintsburg AL, Vasilieva E. Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine. J Immunol 2022;208:1139-45. [PMID: 35101893 DOI: 10.4049/jimmunol.2101052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
13 Sauerwein KMT, Geier CB, Stemberger RF, Akyaman H, Illes P, Fischer MB, Eibl MM, Walter JE, Wolf HM. Antigen-Specific CD4+ T-Cell Activation in Primary Antibody Deficiency After BNT162b2 mRNA COVID-19 Vaccination. Front Immunol 2022;13:827048. [DOI: 10.3389/fimmu.2022.827048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Girl P, Zwirglmaier K, von Buttlar H, Wölfel R, Müller K. Evaluation of Two Rapid Lateral Flow Tests and Two Surrogate ELISAs for the Detection of SARS-CoV-2 Specific Neutralizing Antibodies. Front Med 2022;9:820151. [DOI: 10.3389/fmed.2022.820151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Guiomar R, Santos AJ, Melo AM, Costa I, Matos R, Rodrigues AP, Kislaya I, Silva AS, Roque C, Nunes C, Aguiar J, Graça F, Silva Graça A, Machado A. Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination. Vaccines 2022;10:154. [DOI: 10.3390/vaccines10020154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Saker K, Pozzetto B, Escuret V, Pitiot V, Massardier-pilonchéry A, Mokdad B, Langlois-jacques C, Rabilloud M, Alfaiate D, Guibert N, Fassier J, Bal A, Trouillet-assant S, Trabaud M. Evaluation of Commercial Anti-SARS-CoV-2 Neutralizing Antibody Assays in seropositive subjects.. [DOI: 10.1101/2022.01.04.22268652] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Malipiero G, D'Agaro P, Segat L, Moratto A, Villalta D. Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2. Clin Chim Acta 2022;524:11-7. [PMID: 34843705 DOI: 10.1016/j.cca.2021.11.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
18 Feng Y, Zhang Y, He Z, Huang H, Tian X, Wang G, Chen D, Ren Y, Jia L, Wang W, Wu J, Shao L, Zhang W, Tang H, Wan Y. Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study. EClinicalMedicine 2022;43:101226. [PMID: 34901799 DOI: 10.1016/j.eclinm.2021.101226] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 15.0] [Reference Citation Analysis]
19 Lin Q, Wu J, Liu L, Wu W, Fang X, Kong J. Sandwich/competitive immuno-sensors on micro-interface for SARS-CoV-2 neutralizing antibodies. Anal Chim Acta 2021;1187:339144. [PMID: 34753584 DOI: 10.1016/j.aca.2021.339144] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Zhu F, Althaus T, Tan CW, Costantini A, Chia WN, Van Vinh Chau N, Van Tan L, Mattiuzzo G, Rose NJ, Voiglio E, Wang L. WHO international standard for SARS-CoV-2 antibodies to determine markers of protection. The Lancet Microbe 2021. [DOI: 10.1016/s2666-5247(21)00307-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 23.0] [Reference Citation Analysis]
21 Komissarov AA, Dolzhikova IV, Efimov GA, Logunov DY, Mityaeva O, Molodtsov IA, Naigovzina NB, Peshkova IO, Shcheblyakov DV, Volchkov P, Vasilieva E. Boosting of the SARS-CoV-2-specific immune response after vaccination with single-dose Sputnik Light vaccine.. [DOI: 10.1101/2021.10.26.21265531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 von Metzler I, Campe J, Huenecke S, Raab MS, Goldschmidt H, Schubert R, Rabenau HF, Ciesek S, Serve H, Ullrich E. COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view. J Mol Med (Berl) 2021. [PMID: 34657968 DOI: 10.1007/s00109-021-02114-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Jo DH, Minn D, Lim J, Lee KD, Kang YM, Choe KW, Kim KN. Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination. Vaccines (Basel) 2021;9:1145. [PMID: 34696253 DOI: 10.3390/vaccines9101145] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
24 Piano Mortari E, Russo C, Vinci MR, Terreri S, Fernandez Salinas A, Piccioni L, Alteri C, Colagrossi L, Coltella L, Ranno S, Linardos G, Agosta M, Albano C, Agrati C, Castilletti C, Meschi S, Romania P, Roscilli G, Pavoni E, Camisa V, Santoro A, Brugaletta R, Magnavita N, Ruggiero A, Cotugno N, Amodio D, Ciofi Degli Atti ML, Giorgio D, Russo N, Salvatori G, Corsetti T, Locatelli F, Perno CF, Zaffina S, Carsetti R. Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgA. Cells 2021;10:2541. [PMID: 34685521 DOI: 10.3390/cells10102541] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 32.0] [Reference Citation Analysis]
25 Pratesi F, Caruso T, Testa D, Tarpanelli T, Gentili A, Gioè D, Migliorini P. BNT162b2 mRNA SARS-CoV-2 Vaccine Elicits High Avidity and Neutralizing Antibodies in Healthcare Workers. Vaccines (Basel) 2021;9:672. [PMID: 34207300 DOI: 10.3390/vaccines9060672] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 26.0] [Reference Citation Analysis]